Company Registration No. 14480699 (England and Wales)
Sparrowhawk Pharma Limited
Unaudited accounts
for the year ended 30 November 2024
Sparrowhawk Pharma Limited
Unaudited accounts
Contents
Sparrowhawk Pharma Limited
Company Information
for the year ended 30 November 2024
Directors
Ummer Ayyaz
Ummer Ayyaz
Ummer Ayyaz
Ummer Ayyaz
Ummer Ayyaz
Company Number
14480699 (England and Wales)
Registered Office
14 Altar Drive
Bradford
West Yorkshire
BD9 5QD
England
Sparrowhawk Pharma Limited
Statement of financial position
as at 30 November 2024
Tangible assets
2,536
3,381
Cash at bank and in hand
22,897
55,000
Creditors: amounts falling due within one year
(11,251)
(45,101)
Net current assets
11,646
9,899
Called up share capital
100
100
Profit and loss account
14,082
13,180
Shareholders' funds
14,182
13,280
For the year ending 30 November 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board of Directors and authorised for issue on 31 July 2025 and were signed on its behalf by
Ummer Ayyaz
Director
Company Registration No. 14480699
Sparrowhawk Pharma Limited
Notes to the Accounts
for the year ended 30 November 2024
Sparrowhawk Pharma Limited is a private company, limited by shares, registered in England and Wales, registration number 14480699. The registered office is 14 Altar Drive, Bradford, West Yorkshire, BD9 5QD, England.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
The principal accounting policies adopted in the preparation of the financial statements are set out below and have remained unchanged from the previous year, and also have been consistently applied within the same accounts.
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
The accounts are presented in £ sterling.
Tangible fixed assets and depreciation
Tangible assets are included at cost less depreciation and impairment. Depreciation has been provided at the following rates in order to write off the assets over their estimated useful lives:
4
Tangible fixed assets
Plant & machinery
5
Creditors: amounts falling due within one year
2024
2023
Taxes and social security
8,004
-
Sparrowhawk Pharma Limited
Notes to the Accounts
for the year ended 30 November 2024
6
Average number of employees
During the year the average number of employees was 0 (2023: 0).